Wordt geladen...
Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy. Hypocalcemia and gastrointestinal adverse reactions are the main side effects reported in patients treat...
Bewaard in:
| Gepubliceerd in: | Front Endocrinol (Lausanne) |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308315/ https://ncbi.nlm.nih.gov/pubmed/30622514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00777 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|